2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · IEX Real-Time Price · USD
4.470
-0.050 (-1.11%)
At close: Jul 19, 2024, 4:00 PM
4.480
+0.010 (0.22%)
Pre-market: Jul 22, 2024, 8:05 AM EDT
2seventy bio Employees
2seventy bio had 274 employees as of December 31, 2023. The number of employees decreased by 151 or -35.53% compared to the previous year.
Employees
274
Change (1Y)
-151
Growth (1Y)
-35.53%
Revenue / Employee
$259,858
Profits / Employee
-$814,679
Market Cap
229.78M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 274 | -151 | -35.53% |
| Dec 31, 2022 | 425 | -12 | -2.75% |
| Dec 31, 2021 | 437 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Butterfly Network | 225 |
| NeuroPace | 171 |
| Gossamer Bio | 135 |
| Semler Scientific | 92 |
| Acrivon Therapeutics | 61 |
| Design Therapeutics | 58 |
| Rezolute | 51 |
| ESSA Pharma | 50 |
TSVT News
- 25 days ago - 2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million - Business Wire
- 2 months ago - 2seventy bio to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress - Business Wire
- 2 months ago - 2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024 - Business Wire
- 4 months ago - 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron - Business Wire
- 4 months ago - 2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors - Business Wire
- 4 months ago - 2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress - Business Wire
- 5 months ago - 2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Business Wire